Brain metastases in patients receiving trastuzumab for breast cancer.
Salmaggi
A
A
Dipartimento Neuro-oncologia, Fondazione IRCCS Istituto C. Besta, Via Celoria 11, I-20133 Milan, Italy. salmaggi@istituto-besta.it
Silvani
A
A
Boiardi
A
A
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000209:etiology / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology*; D005260:Female; D006801:Humans; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab